|
Recent Newsletters
Hospital pays $3.8M to resolve allegations | EECP & long COVID | Mortality after TEER | ACC NCDR enrollment |
Heart Rhythm: The first implant of a dual-chamber leadless pacemaker | FDA clears Holter monitor for low-risk patients |
Week in Review: What to expect at ACC.22 | Medtronic's latest recall | The risks of daily acetaminophen use |
Recurrent stroke & marijuana use | Heart drug at center of Olympics controversy | Getinge's big acquisition |
TAVR: An effective treatment for asymptomatic patients | Sapien 3 Ultra THV outperforms its predecessor |
TEE & cardiac surgery | Merger worth $2.4B called off due to ‘unfavorable market conditions’ |
Daily acetaminophen use may be bad for hypertension patients | Late-breaking clinical trials at ACC.22 |